Hisamitsu Pharmaceutical Co.’s management is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be worth around ¥450 billion ($2.9 billion), people familiar with the matter said.
www.bloomberg.com
#CEO #Salonpas #Maker #Seeks #Billion #Drug #Firm #Private
CEO of Salonpas Maker Seeks to Take the $2.9 Billion Drug Firm Private
